Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MICAFUNGIN vs MIDAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MICAFUNGIN vs MIDAZOLAM: Safety Overview

Metric MICAFUNGIN MIDAZOLAM
Total FAERS Reports 3,117 11,192
Deaths Reported 1,068 1,808
Death Rate 34.3% 16.2%
Hospitalizations 1,121 4,691
Average Patient Age 49.7 yrs 41.9 yrs
% Female Patients 38.7% 49.9%
FDA Approval Date Apr 3, 2025 Apr 17, 2023
Manufacturer Zydus Pharmaceuticals USA Inc. SOMERSET THERAPEUTICS, LLC
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Discontinued